Man Group PLC Collegium Pharmaceutical, Inc Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Man Group PLC holds 377,425 shares of COLL stock, worth $11.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

377,425

Previous 260,936 44.64%

Holding current value

$11.4 Million

Previous $10.1 Million 19.98%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$31.36 - $39.99 $3.65 Million - $4.66 Million	116,489 Added 44.64%	377,425 $12.2 Million
Q1 2024 May 15, 2024	BUY	$31.23 - $40.91 $6.4 Million - $8.38 Million	204,957 Added 366.13%	260,936 $10.1 Million
Q4 2023 Feb 14, 2024	SELL	$21.16 - $30.8 $212,975 - $310,002	-10,065 Reduced 15.24%	55,979 $1.72 Million
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $487,101 - $557,080	22,944 Added 53.23%	66,044 $1.48 Million
Q2 2023 Aug 14, 2023	BUY	$21.06 - $24.0 $907,686 - $1.03 Million	43,100 New	43,100 $926,000
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $394,047 - $534,267	-20,470 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$17.83 - $22.29 $26,744 - $33,435	-1,500 Reduced 6.83%	20,470 $410,000
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $30,818 - $40,661	-1,953 Reduced 8.16%	21,970 $457,000
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $131,788 - $200,023	-8,508 Reduced 26.23%	23,923 $419,000
Q1 2020 May 15, 2020	BUY	$13.89 - $25.45 $450,466 - $825,368	32,431 New	32,431 $530,000
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $287,397 - $382,677	-19,445 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $275,341 - $472,513	19,445 New	19,445 $287,000

Others Institutions Holding COLL

# of Institutions

252

Shares Held

38.9M

Call Options Held

84.2K

Put Options Held

19.6K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.03B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account